Agios Fellowships
About Agios
Agios was founded in 2008 to unlock a new field of discovery in cellular metabolism. A singular focus on metabolic disease has taken us from the development of precision therapies in oncology to pioneering new investigational medicines for the treatment of rare diseases. Rooted in hematology, we combine biological expertise with real-world insights to develop innovative medicines that reflect the priorities of rare disease communities. We develop medicines that improve how patients with rare disease feel and function, striving to deliver transformational benefits over existing treatment options. We shift paradigms by prioritizing patients in our decision making, co-designing clinical programs with rare disease communities and partnering with patients. Agios applies a rigorous scientific lens to maximize our current pipeline and prioritize new clinical programs through both internal development and strategic external opportunities across a broad spectrum of rare diseases.
We are a biopharmaceutical company that believes connections unlock potential. We see it in the careers of our people, the evolution of our science, the therapies we are working to bring to market, and the impact we make by working together with patients and collaborators. Each is simply better as a result of the connections we make. By consistently tapping into the knowledge and experience of our patients, partners and colleagues, we elevate our thinking and unearth creative insights that propel ourselves and our science to new levels.
We pride ourselves on fostering an interconnected environment that encourages creative scientific collaboration across disciplines. Our unique culture, combined with the commitment and passion of our team, reflects our belief that we are fueled by connections to transform rare diseases.
Agios/MCPHS Fellowship Program
Agios, in collaboration with MCPHS, offers a unique fellowship program to promote the role of the Doctor of Pharmacy (PharmD) within the biopharmaceutical industry. A fellow gains extensive experiences through various practical activities in both industry and academic settings, which could enhance the potential for accelerated career development. Agios is currently recruiting for the following 2027-2029 fellowship programs:
- Clinical Development, Clinical Scientist
- Clinical Supply Chain
- Medical Safety & Risk Management
The following Agios functional areas develop PharmD fellows, but are not recruiting for the 2027-2029 cycle:
- Medical Affairs (Not recruiting for 2027-2029)
- Clinical GMP Quality Assurance (Not recruiting for 2027-2029)
- Health Economics and Outcomes Research (Not recruiting for 2027-2029)
- Regulatory Affairs (Not recruiting for 2027-2029)
Fellowship Overview
This fellowship program is designed to offer Doctor of Pharmacy graduates in-depth experience within a biopharmaceutical industry setting. In addition, PharmD graduates will have the opportunity to enhance their clinical and academic background in conjunction with MCPHS. Overall, this fellowship program will provide the training and experiences necessary to prepare the fellow for a career in the competitive pharmaceutical industry.
Please see our brochure for additional details and feel free to review the content below.